Counterpoint: The future of innovative epidemiology

American Journal of Epidemiology

Volumn 177, Issue 4, 2013, Pages 281-282

  Ness, Roberta B ^a  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

BEHAVIOR MODIFICATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL PRACTICE; DIET; DRUG EFFICACY; EXERCISE; FOOD INTAKE; HUMAN; NOTE; OBESITY; PRESCRIPTION; SMOKING CESSATION PROGRAM; WEIGHT REDUCTION;

EID: 84873637718     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kws416     Document Type: Note

References (7)

1. Kuller LH. Point: is there a future for innovative epidemiology? Am J Epidemiol. 2013;177(4):279-280.
2. Lenfant C. Clinical research to clinical practice-lost in translation? N Engl J Med. 2003;349(9):868-874.
3. Daneai G, Ding EL, Mozaffarian D, et al. The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med. 6(4):e1000058. (doi:10.1371/journal.pmed. 1000058).
4. Ness RB. Tools for innovative thinking in epidemiology. Am J Epidemiol. 2012;175(8):733-738.
5. Perry C. Lessons from 50 Years of Tobacco Control: Can They Be Applied to Food? Presented at the 2012 International Society for Behavioral Nutrition and Physical Activity Annual Meeting, Austin, Texas, May 23-26, 2012
6. Brownell KD, Frieden TR. Ounces of prevention-the public policy case for taxes on sugared beverages. N Engl J Med. 2009;360(18):1805-1808.
7. Farrelly MC, Niederdeppe J, Yarsevich J. Youth tobacco prevention mass media campaigns: past, present, and future directions. Tob Control. 2003;12(suppl): i35-i47.